Quantum Computing Inc. Announces Attendance at Upcoming Investor Conferences
Get Alerts QUBT Hot Sheet
Join SI Premium – FREE
- Bank of America's Global Technology Conference on
June 2-3, 2026 inSan Francisco - Rosenblatt's 6th Annual Technology Summit on
June 9-10, 2026 , attending virtually - Bank of America's Transforming World Conference on
June 16, 2026 inNew York City - Benchmark's Quantum Computing Summit on
June 17, 2026 inWashington, DC - Northland's Growth Conference on
June 23, 2026 , attending virtually
Please contact your sales representative to register for any of the above conferences.
About Quantum Computing Inc.
Quantum Computing Inc. (Nasdaq: QUBT) is a quantum optics and integrated photonics company focused on delivering accessible, scalable, and cost-effective quantum machines and photonic solutions. The Company provides foundry services for thin-film lithium niobate ("TFLN") photonic chips and offers a vertically integrated portfolio spanning photonics components, subsystems, and full-stack systems.
Designed to operate at room-temperature with low-power requirements, QCi's technologies enable practical deployment across high-growth markets, including high-performance computing, artificial intelligence, cybersecurity, aerospace and defense, and advanced sensing and imaging.
Headquartered in Hoboken, New Jersey, QCi has operations in Arizona, California, Illinois, Massachusetts and Virginia. By combining advanced materials, device engineering, and scalable manufacturing, QCi delivers integrated quantum and photonics technologies, accelerating commercialization and real-world adoption.
Company Contact:
John Nesbett/Zach Nevas
IMS Investor Relations
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/quantum-computing-inc-announces-attendance-at-upcoming-investor-conferences-302786004.html
SOURCE Quantum Computing Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results
- Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Moderna stock pulls back after massive one-day rally: analysts weigh in
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
BofA/Merrill LynchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share